News

A new study concluded physicians frequently deviate from WHO guidelines when treating children and newborns with sepsis. It’s unclear what impact such decisions have on patient outcomes.

A new commentary describes the EEE virus along and points to research and development that is needed to address the growing threat of the virus and other vector-borne conditions.

An analysis of outbreaks shows some helpful trends in toxoplasmosis prevention.

A new study published in Science Translational Medicine reveals that genetic testing can identify patients with leishmaniasis unlikely to respond to conventional treatments, allowing clinicians to find candidates for alternative therapies ahead of time.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of November 17, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A study found that depressive symptoms are associated with higher incidence of HIV transmission for adolescent girls and young women in South Africa, with familial and social factors mediating this association.

Incorporating a signaling protein known as B cell activating factor into the rabies vaccine improved speed and strength of the antibody responses, investigators at Thomas Jefferson University found.

TAF causes cholesterol levels to rise, but that includes levels of “good cholesterol” HDL. Researchers concluded that there is no significant difference in cardiovascular risk profiles between people taking TAF and those taking TDF.

While results of a study on crowdsourced materials promoting hepatitis testing were complicated by intervention sharing, 20% of MSM reported first time testing.

The CDC’s latest report highlights higher rates of infections in the US, but this week let's focus on awareness so we can combat the threat of resistance.

A new study examines the association between vaccine-preventable disease incidence and state vaccine exemption legislation.

Thus far there have been 11 outbreak-associated cases of hepatitis A in Indiana, Nebraska, and Wisconsin.

The sepsis alert system works by monitoring changes in patients’ temperatures, heart rates, and glucose levels, and notifying clinicians of abnormalities through electronic health records.

Existing evidence has suggested a strong biological link between HIV and herpes simplex virus 2 infection.

Two patients with confirmed diagnosis receive care at Beijing hospital and are quarantined, suggesting the outbreak has been controlled.

While perinatally acquired HIV occurrence has decreased since the spread of combination antiretroviral regimens, exposure to efavirenz may increase risk of complications.

Investigators now think that Ebola prevention methods should be a top priority moving forward.

A new study demonstrates that having access to mobile phone location data can provide helpful information on an outbreak’s spread through the urban environment.

An observational study suggests that oral vancomycin may be associated with earlier symptom resolution than metronidazole for children hospitalized with non-severe C diff infections.

After analyzing electronic medical records from 161 patients across 90 VHA sites, investigators determined that patients initiated 94% of conversations about PrEP.

In 2010, Timothy Ray Brown came forward as the "Berlin Patient" and has become an advocate for people living with HIV. He hopes to see the day when all individuals when HIV can be cured safely.

A new rapid blood assay could help physicians to get ahead of sepsis by predicting which patients are at low, medium and high risk for the infection.

While FDA asked for the supplier of yellowfin tuna associated with the majority of illnesses to initiate a voluntary recall, the firm has not recalled any product at this time.

A new commentary outlines the drivers of Hispanic/Latino HIV health disparity, pointing out specific populations which would be key targets for improving HIV prevention and treatment.

From an infection prevention perspective, the nature of Acinetobacter baumannii makes it an organism on the radar for prevention efforts against health care-associated infections.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of November 10, 2019.